Marcy E. Richardson

1.7k total citations
35 papers, 762 citations indexed

About

Marcy E. Richardson is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Marcy E. Richardson has authored 35 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 20 papers in Genetics and 9 papers in Cancer Research. Recurrent topics in Marcy E. Richardson's work include Genomics and Rare Diseases (13 papers), BRCA gene mutations in cancer (12 papers) and Genetic factors in colorectal cancer (8 papers). Marcy E. Richardson is often cited by papers focused on Genomics and Rare Diseases (13 papers), BRCA gene mutations in cancer (12 papers) and Genetic factors in colorectal cancer (8 papers). Marcy E. Richardson collaborates with scholars based in United States, Australia and Spain. Marcy E. Richardson's co-authors include Miles Wilkinson, Deepak Reyon, Vincent Cascio, Quan Ho, J Costello, B Bernstein, Morgan L. Maeder, Samantha J Linder, Jeffry D. Sander and Shengdar Q. Tsai and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Nature Biotechnology.

In The Last Decade

Marcy E. Richardson

28 papers receiving 752 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcy E. Richardson United States 14 558 292 84 65 64 35 762
Betsy Bove United States 11 311 0.6× 336 1.2× 109 1.3× 32 0.5× 74 1.2× 14 633
Sabita K. Murthy Canada 13 371 0.7× 196 0.7× 83 1.0× 28 0.4× 36 0.6× 25 585
Tracy N. Hadnott United States 7 333 0.6× 507 1.7× 66 0.8× 65 1.0× 15 0.2× 11 752
Yitzhak Reizel Israel 14 477 0.9× 108 0.4× 103 1.2× 74 1.1× 25 0.4× 21 665
Sabine Preisler-Adams Germany 10 276 0.5× 368 1.3× 216 2.6× 39 0.6× 75 1.2× 16 687
Kristin Bosse Germany 14 244 0.4× 312 1.1× 56 0.7× 40 0.6× 57 0.9× 24 526
Beike Leegte Netherlands 11 189 0.3× 428 1.5× 91 1.1× 103 1.6× 63 1.0× 15 531
Gaetano Verde Spain 14 934 1.7× 591 2.0× 86 1.0× 11 0.2× 28 0.4× 16 1.1k
Sandrine M. Caputo France 14 448 0.8× 340 1.2× 77 0.9× 19 0.3× 59 0.9× 29 607
Estela G. Toraño Spain 9 292 0.5× 82 0.3× 61 0.7× 86 1.3× 29 0.5× 9 431

Countries citing papers authored by Marcy E. Richardson

Since Specialization
Citations

This map shows the geographic impact of Marcy E. Richardson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcy E. Richardson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcy E. Richardson more than expected).

Fields of papers citing papers by Marcy E. Richardson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcy E. Richardson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcy E. Richardson. The network helps show where Marcy E. Richardson may publish in the future.

Co-authorship network of co-authors of Marcy E. Richardson

This figure shows the co-authorship network connecting the top 25 collaborators of Marcy E. Richardson. A scholar is included among the top collaborators of Marcy E. Richardson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcy E. Richardson. Marcy E. Richardson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fortuño, Cristina, Adam Chamberlin, Bing Feng, et al.. (2025). Integration of protein stability and AlphaMissense scores improves bioinformatic impact prediction for p53 missense and in-frame amino acid deletion variants. The American Journal of Human Genetics. 112(5). 1003–1014. 1 indexed citations
2.
Fortuño, Cristina, Adam Chamberlin, Marcy E. Richardson, et al.. (2025). ACMG/AMP interpretation of BRCA1 missense variants: Structure-informed scores add evidence strength granularity to the PP3/BP4 computational evidence. The American Journal of Human Genetics. 112(5). 993–1002. 1 indexed citations
3.
Richardson, Marcy E., et al.. (2025). Structural biology in variant interpretation: Perspectives and practices from two studies. The American Journal of Human Genetics. 112(5). 984–992.
4.
Fortuño, Cristina, Marcy E. Richardson, Tina Pesaran, et al.. (2025). Characteristics predicting reduced penetrance variants in the high-risk cancer predisposition gene TP53. Human Genetics and Genomics Advances. 6(4). 100484–100484.
5.
Bychkovsky, Brittany, Nihat Buğra Ağaoğlu, Carolyn Horton, et al.. (2025). Double CHEK2 Pathogenic and Low-Risk Variants and Associated Cancer Phenotypes. JAMA Network Open. 8(1). e2451361–e2451361. 1 indexed citations
6.
Young, Colin C., Carolyn Horton, Bhuvan Molparia, et al.. (2024). Solving Missing Heritability in Patients With Familial Adenomatous Polyposis With DNA-RNA Paired Testing. JCO Precision Oncology. 8(8). e2300404–e2300404. 3 indexed citations
7.
Ağaoğlu, Nihat Buğra, Brittany Bychkovsky, Carolyn Horton, et al.. (2024). Cancer burden in individuals with single versus double pathogenic variants in cancer susceptibility genes. SHILAP Revista de lepidopterología. 2. 101829–101829. 5 indexed citations
8.
Lerner, Benjamin A., Marcy E. Richardson, Lisa R. Susswein, et al.. (2024). Validation of the NCCN/Yale criteria for the identification of CDH1 pathogenic variant carriers. Journal of Medical Genetics. 62(2). 57–61.
9.
Yussuf, Amal, et al.. (2023). Characterization of POT1 tumor predisposition syndrome: Tumor prevalence in a clinically diverse hereditary cancer cohort. Genetics in Medicine. 25(11). 100937–100937. 6 indexed citations
10.
Horton, Carolyn, Lily Hoang, Heather Zimmermann, et al.. (2023). Diagnostic Outcomes of Concurrent DNA and RNA Sequencing in Individuals Undergoing Hereditary Cancer Testing. JAMA Oncology. 10(2). 212–212. 14 indexed citations
11.
Foo, Tzeh Keong, Marcy E. Richardson, John Michael O. Rañola, et al.. (2023). BRCA1 frameshift variants leading to extended incorrect protein C termini. Human Genetics and Genomics Advances. 4(4). 100240–100240.
12.
Hernandez, Felicia, et al.. (2021). Classification of the canonical splice alteration MUTYH c.934-2A > G is likely benign based on RNA and clinical data. Molecular Case Studies. 8(1). a006152–a006152. 1 indexed citations
13.
Bychkovsky, Brittany, Min‐Tzu Lo, Amal Yussuf, et al.. (2021). Prevalence and spectrum of pathogenic variants among patients with multiple primary cancers evaluated by clinical characteristics. Cancer. 128(6). 1275–1283. 13 indexed citations
14.
Richardson, Marcy E., Chunling Hu, Kun Y. Lee, et al.. (2021). Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significance. The American Journal of Human Genetics. 108(3). 458–468. 29 indexed citations
15.
Hartman, Tiffiney R., Lily Hoang, Marcy E. Richardson, et al.. (2020). Prevalence of pathogenic variants in DNA damage response and repair genes in patients undergoing cancer risk assessment and reporting a personal history of early-onset renal cancer. Scientific Reports. 10(1). 13518–13518. 15 indexed citations
16.
Lyra, Paulo C., Letícia Batista Azevedo Rangel, Marcy E. Richardson, et al.. (2020). Integration of functional assay data results provides strong evidence for classification of hundreds of BRCA1 variants of uncertain significance. Genetics in Medicine. 23(2). 306–315. 17 indexed citations
17.
Ivanovich, Jennifer, Marc R. Radke, Marcy E. Richardson, et al.. (2019). Rare BRIP1 Missense Alleles Confer Risk for Ovarian and Breast Cancer. Cancer Research. 80(4). 857–867. 33 indexed citations
18.
Richardson, Marcy E., Hansook Kim Chong, Wenbo Mu, et al.. (2018). DNA breakpoint assay reveals a majority of gross duplications occur in tandem reducing VUS classifications in breast cancer predisposition genes. Genetics in Medicine. 21(3). 683–693. 15 indexed citations
19.
Song, H. C., Anilkumar Bettegowda, Blue B. Lake, et al.. (2016). The Homeobox Transcription Factor RHOX10 Drives Mouse Spermatogonial Stem Cell Establishment. Cell Reports. 17(1). 149–164. 42 indexed citations
20.
Rao, Manjeet K., Yuiko Matsumoto, Marcy E. Richardson, et al.. (2014). Hormone-induced and DNA Demethylation-induced Relief of a Tissue-specific and Developmentally Regulated Block in Transcriptional Elongation. Journal of Biological Chemistry. 289(51). 35087–35101. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026